1. Home
  2. RILY vs DERM Comparison

RILY vs DERM Comparison

Compare RILY & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RILY
  • DERM
  • Stock Information
  • Founded
  • RILY 1973
  • DERM 2014
  • Country
  • RILY United States
  • DERM United States
  • Employees
  • RILY N/A
  • DERM N/A
  • Industry
  • RILY Investment Managers
  • DERM Biotechnology: Pharmaceutical Preparations
  • Sector
  • RILY Finance
  • DERM Health Care
  • Exchange
  • RILY Nasdaq
  • DERM Nasdaq
  • Market Cap
  • RILY 154.9M
  • DERM 165.6M
  • IPO Year
  • RILY 2007
  • DERM 2021
  • Fundamental
  • Price
  • RILY $6.22
  • DERM $7.11
  • Analyst Decision
  • RILY
  • DERM Strong Buy
  • Analyst Count
  • RILY 0
  • DERM 3
  • Target Price
  • RILY N/A
  • DERM $12.67
  • AVG Volume (30 Days)
  • RILY 1.0M
  • DERM 154.9K
  • Earning Date
  • RILY 11-13-2025
  • DERM 11-11-2025
  • Dividend Yield
  • RILY N/A
  • DERM N/A
  • EPS Growth
  • RILY N/A
  • DERM N/A
  • EPS
  • RILY N/A
  • DERM N/A
  • Revenue
  • RILY $639,161,000.00
  • DERM $56,397,000.00
  • Revenue This Year
  • RILY N/A
  • DERM $28.10
  • Revenue Next Year
  • RILY N/A
  • DERM $53.84
  • P/E Ratio
  • RILY N/A
  • DERM N/A
  • Revenue Growth
  • RILY N/A
  • DERM N/A
  • 52 Week Low
  • RILY $2.67
  • DERM $3.54
  • 52 Week High
  • RILY $7.43
  • DERM $8.90
  • Technical
  • Relative Strength Index (RSI)
  • RILY 60.87
  • DERM 47.18
  • Support Level
  • RILY $4.85
  • DERM $6.88
  • Resistance Level
  • RILY $5.40
  • DERM $7.12
  • Average True Range (ATR)
  • RILY 0.46
  • DERM 0.29
  • MACD
  • RILY 0.04
  • DERM 0.00
  • Stochastic Oscillator
  • RILY 77.66
  • DERM 32.20

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: